HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- (3- ((6- chlorothiazolo(5,4- b)pyridin- 2- yl)methoxy)- 2,6- difluorobenzoyl)- 1- methylpiperidine- 4- carboxamide

prodrug of PC190723; structure in first source

Also Known As:

TXY541

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - N-(3-((6-chlorothiazolo(5,4-b)pyridin-2-yl)methoxy)-2,6-difluorobenzoyl)-1-methylpiperidine-4-carboxamide: 1
Organic Chemicals: 133
- Imides: 79
  - N-(3-((6-chlorothiazolo(5,4-b)pyridin-2-yl)methoxy)-2,6-difluorobenzoyl)-1-methylpiperidine-4-carboxamide: 1

Experts

1.	Kaul, Malvika: 1 article (12/2013)
2.	LaVoie, Edmond J: 1 article (12/2013)
3.	Mark, Lilly: 1 article (12/2013)
4.	Parhi, Ajit K: 1 article (12/2013)
5.	Pilch, Daniel S: 1 article (12/2013)
6.	Zhang, Yongzheng: 1 article (12/2013)

Related Diseases

1.	Infections 12/15/2013 - "Whether administered orally or intravenously, TXY541 was found to be efficacious in vivo in mouse models of systemic infection with both methicillin-sensitive and methicillin-resistant S. "

Related Drugs and Biologics

1.	Methicillin (Metin)